Under construction – not a live service
Sign in
Taking people in United KingdomNo phase

Studies gut and lung bacteria in children with breathing and stomach problems

Compares gut and lung microbes in children with breathing, stomach or asthma conditions.

Plain-language title generated from the registry record
Registry title: The Gut-Lung Axis and Respiratory Illness in Children

Key facts

Where
Glasgow, United KingdomSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 0 and 16 years old?

Source: NCT06271213, who can take part

Where in United Kingdom

  • NHS Greater Glasgow and Clyde: Royal Hospital for children, GlasgowGlasgow, United KingdomTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
NHS Greater Glasgow and Clyde
Trial code
NCT06271213
Record updated
21 February 2024
Original description
The goal of this single-centre observational study conducted at the Royal Hospital for Children in Glasgow, Scotland, is to employ a multi-omics approach to investigate the "gut-lung axis" in health and disease.Read full original descriptionShow less

The Gut-Lung Axis and Respiratory Illness in Children

The goal of this single-centre observational study conducted at the Royal Hospital for Children in Glasgow, Scotland, is to employ a multi-omics approach to investigate the "gut-lung axis" in health and disease.

Part A is a cross-sectional study design investigating the postulated bidirectional link between the gut and lung microbiomes in children suffering from respiratory or gastrointestinal conditions. Children with no GI or respiratory issues attending for orthopaedic care will be used as a benchmark for a healthy gut-lung axis. The main questions we aim to answer are:

* What does a healthy gut-lung axis look like? * Do children with respiratory issues show an altered gut microbiome? * Do children with GI issues show an altered lung microbiome?

Part B is a longitudinal study design, that aims to assess the effects of biologics on the gut-lung axis by comparing the gut and lung microbiomes in children with asthma at two time-points who are indicated to start biologics therapy (Asthma treatment) or will not receive biologics therapy (asthma control).

Participants will provide:

* airway samples (to investigate the lung microbiome) * blood samples (to assess inflammatory and metabolic factors which may mediate communication between the two sites) whilst under general anaesthetic for a treatment related to their standard of care * stool samples (to assess gut microbiome) * dietary information (food diary and/or food frequency questionnaire) to assess relationships between diet and the gut-lung axis.

Inclusion: Any infant/child/young person admitted to the RHC, Glasgow for an elective bronchoscopy or GI endoscopy; Any infant/child attending for an emergency/elective orthopaedic operation without active respiratory or gastrointestinal conditions or receiving treatment for either condition. (Age range birth to 16 years for all groups recruited); Any child attending respiratory department at RHC who can induce sputum and is having a blood sample taken, with latter part of standard of care; Any infant/child/young person admitted to RHC for a clinical care appointment with Asthma/wheeze before commencement of biologics therapy (treatment group); Any child admitted to RHC with asthma/wheeze not indicated for biologic therapy (asthma control group).

Exclusion: Use of antibiotics by the day of admission or have used antibiotics in the previous month (unless prophylactic antibiotics > 1 month use); Any child with Asthma currently receiving Biologics therapy (unless recruited via bronchoscopy route); Any child known to be infected with, or at high risk of having had exposure to HIV, hepatitis B or hepatitis C viruses; Any person 17 years old and above; . Any child and/or parent/guardian who cannot understand the English language where consent would be unethical.

ClinicalTrials.gov NCT06271213